LEFT VENTRICULAR LEAD IMPLANTATION FOR DETECTION OF VENTRICULAR ARRHYTHMIAS IN PATIENT WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AND LOW R WAVE IN RIGHT VENTRICLE


LEFT VENTRICULAR LEAD IMPLANTATION FOR DETECTION OF VENTRICULAR ARRHYTHMIAS IN PATIENT WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AND LOW R WAVE IN RIGHT VENTRICLE


Zebrauskaite A1*, Kiernan TJ1,2, Hennessy T1

1Department of Cardiology, University Hospital Limerick, Limerick, Ireland. 2Graduate Entry Medical School, University of Limerick, Limerick, Ireland.


Dilated cardiomyopathy (DCM) is a disease characterised as left ventricular (LV) or biventricular dilatation with impaired systolic function. Regardless of underlying cause patients with DCM have a propensity to ventricular arrhythmias and sudden cardiac death. Implantable Cardioverter Defibrillator (ICD) implantation for these patients results in significant reduction of sudden cardiac death [1-3]. ICD devices may be limited by right ventricle (RV) sensing dysfunction with low RV sensing amplitude. We present a clinical case of patient with DCM, implanted ICD and low R wave sensing on RV lead.


Keywords: DCM, ICD, LV

Free Full-text PDF


How to cite this article:
Zebrauskaite A, Kiernan TJ, Hennessy T. Left Ventricular Lead Implantation for detection of ventricular arrhythmias in Patient with Implantable Cardioverter Defibrillator and low R Wave in Right Ventricle .American Journal of Cardiology Research and Reviews, 2021, 4:17. DOI:10.28933/ajcrar-2021-10-1005


References:
1. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable de-fibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–1302.
2. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000; 21:2071–2078.
3. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evalu-ation Investigators. Prophylactic defibrillator im-plantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151–2158.
4. Priori SG, Blomstro C, Mazzanti A, Blom N, Borggrefe M, Camm J et al.2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theEu-ropean Society of Cardiology. European Heart Journal 2015;36:2793–2867.
5. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2017 Nov 3. pii: S1547-5271(17) 31251-1.
6. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardiovert-er-defibrillator programmingand testing. J Ar-rhythm 2016;32:1–28.
7. Dekker LR, Schrama TA, Steinmetz FH, Tukkie Rl. Undersensing of VF in a patient withoptimal R wave sensing during sinus rhythm. Pacing Clin Electrophysiol 2004;27:833–4.
8. Lillo-Castellano JM, Marina-Breysse M,1 Gómez-Gallanti A, Martínez-Ferrer JB, Alzueta J, Pérez-Álvarez L et al. Safety threshold of R-wave amplitudes in patients with implantable cardio-verter defibrillator. Heart 2016;102:1662–1670.
9. Lochy S, Francois B, Hollanders G, Provenier F. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular car-diomyopathy. Europace. 2010 Aug;12(8):1195 -6.


Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details). This site cannot and does not contain professional advice. The information on this site is provided for general informational and educational purposes only and is not a substitute for professional advice. Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of professional advice. The use or reliance of any information contained on this site or our mobile application is solely at your own risk. Under no circumstance shall we have any liability to you for any loss or damage of any kind incurred as a result of the use of the site or our mobile application or reliance on any information provided on the site and our mobile application. We may publish articles without peer-review. Published articles of authors are open access. Authors hold the copyright and retain publishing rights without restrictions. Authors are solely responsible for their articles published in our journals. Publication of any information in authors’ articles does not constitute an endorsement by us. We make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information that authors provided. more..


CC BY 4.0
This work and its PDF file(s) are licensed under a Creative Commons Attribution 4.0 International License.